Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification

Journal:

Journal of Hepatology

Published:

2025-07-16

DOI:

10.1016/j.jhep.2025.06.034

Affiliations:

5

Authors:

17

Go to article

Institutions	Authors	Share
Li Ka Shing Faculty of Medicine, HKU, China	6.866667	0.40
The University of Hong Kong (HKU), China	6.866667	0.40
Centre for Oncology and Immunology, China	2.866667	0.17
The University of Hong Kong - Shenzhen Hospital (HKU-SZH), China	0.200000	0.01
Guangdong-Hong Kong Joint Laboratory for RNA Medicine, China	0.200000	0.01

Interested in Oncology and Carcinogenesis?